Skip to product information
1 of 1

GeneBio Systems

Recombinant Human Caspase-10/CASP10 Protein (His Tag)

Recombinant Human Caspase-10/CASP10 Protein (His Tag)

SKU:PKSH032176

Regular price €355,95 EUR
Regular price Sale price €355,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size: 50μg

Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.

Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.

Exp date: 12 months

Category ID_II: Recombinant Proteins

Category ID_III: Others

Abbreviation: Caspase-10;CASP10

Target Synonym: Apoptotic Protease Mch-4;CASP-10;CASP10;Caspase-10;FAS-Associated Death Domain Protein Interleukin-1B-Converting Enzyme 2;FLICE2;ICE-Like Apoptotic Protease 4;MCH4

Research Areas: Cell Biology,Cancer,Metabolism

Conjugation:

Target Species: Human

Expression Host: E.coli

Application:

Fusion tag: C-His

UNIProt ID: Q92851

Accession: Q92851-4

Background: Caspase-10 (CASP10) is a 521 amino acid protein member of the Cysteine-Aspartic Acid Protease (Caspase) family. CASP10 contains two DED (Death Effector) domains and is detectable in most tissues. CASP10 cleavage by Granzyme B and autocatalytic activity generate the two active subunits: Caspase-10 subunit p23/17, Caspase-10 subunit p12. Caspases are a family of cytosolic aspartate-specific cysteine proteases involved in the execution-phase of cell apoptosis, the initiation and execution. Human caspases can be subdivided into three functional groups: cytokine activation (caspase-1, -4, -5, and -13), apoptosis initiation (caspase-2, -8, -9, -and -10), and apoptosis execution (caspase-3, -6, and -7). CASP10 cleaves and activates caspases 3 and 7, but itself is processed by caspase 8. Defects in CASP10 are associated with apoptosis defects seen in type II autoimmune lymphoproliferative syndrome.

Concentration:

Activity: Not validated for activity

Sequence: Val220-Ile480

Purity: > 70 % as determined by reducing SDS-PAGE.

Formulation: Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 8% Sucrose, 1mM DTT, 0.05% Tween 80, pH8.5.

Reconstitution: Not Applicable

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.

Calculated MW: 30.1 kDa

ObservedMW: 33 kDa

View full details